Diagnostic imaging platform has raised £9.6 million funding to expand its reach in the United States. offers an appointment booking engine for patients, a portal for referring providers, and an API for digital health partners.

It has a network of over 50 imaging centres and says it reached $1 million in annualised revenue in the first five weeks of its US launch in February 2023.

The London- and Atlanta-based company will expand into five additional US states and secure enterprise contracts with payers and digital health platforms. 

The Series A funding round was co-led by Aviva Ventures, YZR Capital, Oxford Capital, Triple Point Ventures, and Simplyhealth Ventures, with participation from Forefront Venture Partners.

It will also be used to develop bespoke products for UK insurers to accelerate the healthcare referral process., which raised £2.2m led by Triple Point Ventures in September 2022, currently receives referrals from hundreds of clinicians, consultants, sporting and healthcare industry bodies, telehealth providers, and insurers every month, including from strategic partners Simplyhealth.

“We are thrilled to have such strong support from our investors as we continue to build across the UK and US,” said co-founder and CEO Charlie Bullock. 

“The capital will be used to continue to improve access to diagnostic imaging and medical screening exams, through our consumer-facing marketplace and API. 

“This round would not have been possible without the incredible effort and tenacity shown by our entire team, who have built at such a fast pace in what is traditionally a very slow-moving industry.”

How will drone tech revolutionise medical deliveries?

Rupert Novis, director of Simplyhealth Ventures, said: “Our expanding partnership with will allow our customers to book MRI, CT, X-ray, and Ultrasound scans online in minutes, without a referral from a GP. 

“’s aim of making booking a diagnostic scan as easy as booking a hotel room aligns perfectly with our purpose of improving access to healthcare for everyone in the UK. We are proud to be investing in to help accelerate the development of predictive and preventative services across the changing healthcare landscape.”